You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

unknown primary

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)

Recruiting
  • Unknown Primary Tumors
  • Oropharynx Cancer
  • Detection of lesions using fluorescence molecular imaging
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 20, 2023

Cancer of Unknown Primary Site, Unknown Primary Cancer, Unknown Primary, Squamous Cell Carcinoma Trial in Copenhagen, Århus

Recruiting
  • Cancer of Unknown Primary Site
  • +2 more
  • Transoral Ultrasound
  • Copenhagen, Denmark
  • +1 more
May 2, 2023

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Recruiting
  • Unknown Primary Tumors
  • DNA Methylation
    • Guangzhou, Guangdong, China
      Sun Yat-sen university cancer center
    Nov 20, 2023

    Cancer of Unknown Primary Site Trial in Houston (Sintilimab)

    Recruiting
    • Cancer of Unknown Primary Site
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)

    Not yet recruiting
    • Head and Neck Cancer
    • +2 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Jan 18, 2023

    Carcinoma of Unknown Primary: A Comparison Across Tissue and

    Recruiting
    • Cancer of Unknown Primary Site
      • Bath, United Kingdom
      • +6 more
      Oct 18, 2022

      Neuroendocrine Tumors, Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors Trial in New York (177Lu-DOTATATE)

      Recruiting
      • Neuroendocrine Tumors
      • Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 19, 2023

      Analgesia, Surgery, Cancer of Head and Neck Trial in Copenhagen (Dexamethasone, Placebo)

      Active, not recruiting
      • Analgesia
      • +6 more
      • Copenhagen, Denmark
        Department of Otorhinolaryngology, Head and Neck Surgery & Audio
      Oct 14, 2022

      Cancer of Unknown Primary Site Trial in Bendigo, Melbourne, Warrnambool (68Ga-FAPi-46, PET/CT imaging)

      Not yet recruiting
      • Cancer of Unknown Primary Site
      • Bendigo, Victoria, Australia
      • +2 more
      Feb 28, 2022

      Carcinoma of Unknown Primary Trial in Calgary, Edmonton, Ottawa (Pembrolizumab Injection)

      Recruiting
      • Carcinoma of Unknown Primary
      • Pembrolizumab Injection
      • Calgary, Alberta, Canada
      • +2 more
      Feb 18, 2022

      Cancer of Unknown Primary Site Trial in Shanghai (tissue-of-origin (ORIGIN-PanCA?R) profiling)

      Completed
      • Cancer of Unknown Primary Site
      • tissue-of-origin (ORIGIN-PanCA○R) profiling
      • Shanghai, China
        Fudan University Cancer Hospital
      Jan 21, 2022

      Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab Trial in Shanghai (Tislelizumab plus chemo)

      Recruiting
      • Cancer of Unknown Primary
      • +5 more
      • Tislelizumab plus chemotherapy
      • Shanghai, Shanghai, China
        ChangZheng Hospital
      Feb 6, 2022

      Positron Emission Tomography in Detecting Primary Tumor in Cases

      Recruiting
      • Metastasis of Unknown Origin
      • PET/CT
      • Sohag, Egypt
        Sohag university Hospital
      Oct 11, 2023

      Integrated Molecular Profiling in Advanced Cancers Trial

      Active, not recruiting
      • Breast Cancer
      • +9 more
        • Toronto, Ontario, Canada
          Princess Margaret Hospital
        Sep 26, 2022

        Circulating Biomarkers in Oropharyngeal Cancers

        Active, not recruiting
        • Oropharynx Squamous Cell Carcinoma
        • +3 more
          • Orebro, Sweden
            Anna Oldaeus Almerén
          Jun 13, 2023

          Cancer of Unknown Primary Trial in Shanghai (Recombinant humanized anti-PD-1 mAb injection)

          Recruiting
          • Cancer of Unknown Primary
          • Recombinant humanized anti-PD-1 monoclonal antibody injection
          • Shanghai, China
            Fudan University Shanghai Cancer Center
          Apr 18, 2022

          Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma, Unknown Primary Trial in Liverpool (Versius Surgical System)

          Not yet recruiting
          • Squamous Cell Carcinoma of the Oropharynx
          • Squamous Cell Carcinoma, Unknown Primary
          • Versius Surgical System
          • Liverpool, United Kingdom
            Liverpool Head and Neck Centre, ENT Department Liverpool Univers
          Oct 27, 2023

          Solving Riddles Through Sequencing

          Recruiting
          • Leukemia
          • +5 more
          • Next Generation Sequencing
          • Munich, Germany
            MLL Munich Leukemia Laboratory
          Jan 19, 2022

          First-line Treatment Among Cancer of Unknown Primary in China

          Recruiting
          • Cancer of Unknown Primary Site
          • no intervention
          • Shanghai, Shanghai, China
            Fudan University Shanghai Cencer Center
          Jul 6, 2021

          Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

          Recruiting
          • Breast Cancer
          • +10 more
            • Hamilton, Ontario, Canada
            • +6 more
            Apr 21, 2022

            Solid Tumor, Microsatellite Instability, Mismatch Repair Deficiency Trial in Australia (APL-501)

            Completed
            • Solid Tumor
            • +3 more
            • Camperdown, New South Wales, Australia
            • +4 more
            May 5, 2022

            Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

            Recruiting
            • Non Small Cell Lung Cancer
            • +6 more
            • Fairfax, Virginia
              NEXT Oncology
            Jun 7, 2023

            Rare Cancers, Cholangiocarcinoma, Cancer of Unknown Primary Site Trial in Cambridge (FoundationOne CDx and FoundationOne Liquid

            Recruiting
            • Rare Cancers
            • +2 more
            • FoundationOne CDx and FoundationOne Liquid CDx
            • Cambridge, Massachusetts
              TargetCancer Foundation
            Oct 13, 2021

            Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,

            Recruiting
            • Malignant Digestive System Neoplasm
            • +12 more
            • Computed Tomography
            • +4 more
            • Houston, Texas
              M D Anderson Cancer Center
            Sep 22, 2022

            Heart Failure, COPD, Diabetes Trial in Milan (Outpatient visit)

            Recruiting
            • Heart Failure
            • +7 more
            • Outpatient visit
            • Milan, Italy
              San Raffaele Hospital
            Feb 3, 2023